At A Glance
1
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees63
Fundamentals
How The Business Makes Money
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults. It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.
Industry Drug Manufacturers - Specialty & Generic
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIKUNKNOWN_SHIEF
ISINGB00BYV81293
Phone44 1915 118 500
AddressNorthern Design Centre, Gateshead, NE8 3DF, GB
SEC EDGAR